Protective effect of poly(ADP-ribose) polymerase inhibitors against cell damage induced by antiviral and anticancer drugs

Cell Death: The Role of Poly (ADP-ribose) Polymerase

Volumn , Issue , 2000, Pages 167-182

  Sümegi, Balázs ^a   Rablóczky, György ^b   Rácz, Ildikó ^b   Tory, Kálmán ^b   Bernáth, Sándor ^b   Várbiró, Gábor ^a   Gallyas, Ferenc ^a   Nagy, Péter Literati ^b  

^a UNIVERSITY OF PÉCS   (Hungary)

^b N Gene Res Labs Incorporation   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 2042430193     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9781420038897     Document Type: Chapter

References (78)

1. Lindahl, T., Satoh, M. S., Poirier, G. G., and Klungland, A., Post-translational modification of poly(ADP-ribose) polymerase induced by DNA strand breaks, Trends Biochem. Sci., 20, 405, 1995.
2. Radons, J., Heller, B., Burkle, A., Hartmann, B., Rodriguez, M. L,. Kröncke, K. D., Burkart, V., and Kolb, H., Nitric oxide toxicity in islet cells involves poly(ADPribose) polymerase activation and concomitant NAD+ depletion, Biochem. Biophys. Res. Commun., 199, 1270, 1994.
3. Janero, D. R., Hreniuk, D., Sharif, H. M., and Prout, K. C., Hydroperoxide-induced oxidative stress alters pyridine nucleotide metabolism in neonatal heart muscle cells, Am. J. Physiol., 264, C1401, 1993.
4. Turrens, J. F., Beconi, M., Barilla, J., Chavez, U. B., and McCord, J. M., Mitochondrial generation of oxygen radicals during reoxygenation of ischemic tissues, Free Radical Res. Commun., 12-13, 681, 1991.
5. Ambrosio, G., Zweier, J. L., Duilio, C., Kuppusamy, P., Santoro, G., Elia, P. P., Tritto, I., Cirillo, P., Condorelli, M., and Chiariello., M., Evidence that mitochondrial respiration is a source of potentially toxic oxygen free radicals in intact rabbit hearts subjected to ischemia and reflow, J. Biol. Chem., 268, 18532, 1993.
6. Vanden-Hoek, T. L., Becker, L. B., Shao, Z., Li, C., and Schumacker, P. T., Reactive oxygen species released from mitochondria during brief hypoxia induce preconditioning in cardiomyocytes, J. Biol. Chem., 273, 18092, 1998.
7. Takeyama, N., Matsuo, N., and Tanaka, T., Oxidative damage to mitochondria is mediated by the Ca(2+)-dependent inner-membrane permeability transition, Biochem. J., 294, 719, 1993.
8. Halestrap, A. P., Kerr, P. M., Javadov, S., and Woodfield, K. Y., Elucidating the molecular mechanism of the permeability transition pore and its role in reperfusion injury of the heart, Biochim. Biophys. Acta, 1366, 79, 1998.
9. Lemasters, J. J., Nieminen, A. L., Qian, T., Trost, L. C., Elmore, S. P., Nishimura, Y., Crowe, R. A., Cascio, W. E., Bradham, C. A., Brenner, D. A., and Herman, B., The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy, Biochim. Biophys. Acta, 1366, 177, 1998.
10. Cuzzocrea, S., Zingarelli, B., and Caputi, A. P., Peroxynitrate-mediated DNA strand breakage activates poly(ADP-ribose) synthetase and causes cellular energy depletion in a nonseptic shock model induced by zymosan in the rat, Shock, 9, 336, 1998.
11. Szabó, C., Virág, L., Cuzzocrea, S., Scott, G. S., Hake, P., O’Connor, M. P., Zingarelli, B., Salzman, A. L., and Kun, E., Protection against peroxynitrite-induced fibroblast injury and arthritis development by inhibition of poly(ADP-ribose) synthase, Proc. Natl. Acad. Sci. U.S.A., 95, 3867, 1998.
12. Copeland, W. C., Cheng, M. S., and Wang, T. S. F., Human DNA polymerase are able to incorporate anti-HIV deoxynucleotides into DNA, J. Biol. Chem., 267, 21459, 1992.
13. Meng, T. C., Fischl, M. A., Boota, A. M., Spector, S. A., Bennett, D., Bassiakos, Y., Lai, S. H., Wright, B., and Richman, D. D., Combination therapy with zidovudine and dideoxycytidine in patients with advanced human immundeficiency virus infection: a phase I/II study, Ann. Intern. Med., 116, 13, 1992.
14. Lipsky, J. J., Zalcitabine and didanosine, Lancet, 341, 30, 1993.
15. Von der Helm, K., Retroviral proteases: structure, function and inhibition from a nonanticipated viral enzyme to the target of a most promising HIV therapy, Biol. Chem., 377, 765, 1996.
16. Deminie, C. A., Bechtold, C. M., Stock, D., Alam, M., Djang, F., Balch, A. H., Chou, T. C., Prichard, M., Colonno, R. J., and Lin, P. F., Evaluation of reverse transcriptase and protease inhibitors in two-drug combinations against human immundeficiency virus replication, Antimicrob. Agents Chemother., 40, 1346, 1996.
17. Indorf, A. M. and Pergam, P. S., Esophageal ulceration related to zalcitabine(ddC), Ann. Intern. Med., 117, 133, 1992.
18. Lerza, R., Castello, G., Mela, G. S., Arboscello, E., Cerruti, A., Bogliolo, G., Mencoboni, M., Ballarino, P., and Pannacciulli, I., In vitro synergistic inhibition of human bone marrow hemopoetic progenitor growth by a 3′-azido-3′deoxy-thymidine, 2′,3′-dideoxycytidine combination, Exp. Hematol., 25, 252, 1997.
19. Izuta, S., Saneyoshi, M., Sakurai, T., Suzuki, M., Kojima, K., and Yoshida, S., The 5′-triphosphates of azido-3′-dezoxythymidine and 2′,3′-dideoxynucleosides inhibit DNA polymerase gamma by different mechanisms, Biochem. Biophys. Res. Commun., 179, 776, 1991.
20. Chen, C. H., Vazquez Padua, M., and Cheng, Y. C., Effect of anti-human immundeficiency virus nucleoside analogs on mitochondrial DNA and its implication for delayed toxicity, Mol. Pharmacol., 39, 625, 1991.
21. Herskowitz, A., Willoughby, S. B., Baughman, K. L., Schulman, S. P., and Bartlett, J. D., Cardiomyopathy associated with antiretroviral therapy in patients with HIV infection, Ann. Intern. Med., 116, 311, 1992.
22. Lewis, L. D., Hamzeh, F. M., and Lietman, P. S., Ultrastructural changes associated with reduced mitochondrial DNA and impaired mitochondrial function in the presence of 2′,3′-dideoxycytidine, Antimicrob. Agents Chemother., 36, 2061, 1992.
23. Skuta, G., Fischer, M. G., Janaky, T., Kele, Z., Szabó, P., Tozser, J., and Sumegi, B., Molecular mechanism of the short term cardiotoxicity caused by 2′,3′dideoxycytidine (ddC): modulation of reactive oxygen species levels and ADP ribosylation reactions, Biochem. Pharmacol., 59, 937, 2000.
24. Szabados, E., Fischer, M. G., Toth, K., Csete, B., Nemeti, B., Trombitas, K., Habon, T., Endrei, D., and Sumegi, B., Role of reacrive oxygen species and poly-ADP-ribose polymerase in the development of AZT-induced cardiomyopathy in rat, Free Radical Biol. Med., 26, 309, 1999.
25. Szabados, E., Literati-Nagy, P., Farkas, B., and Sumegi, B., BGP-15, a nicotinic amidoxime derivate protecting heart from ischemia-reperfusion injury through modulation of poly(ADP-ribose) polymerase activity, Biochem. Pharmacol., 58, 1915, 1999.
26. Raymond, P., Blais, C., Jr., Decarie, A., Morais, R., and Adam, A., Zidovudine potentiates local and systemic inflammatory responses in the rat, J. Acquired Immune Deficiency Syndr. Hum. Retrovirol., 14, 399, 1997.
27. Ensoli, F., Fiorelli, V., DeCristofaro, M., Santini Muratori, D., Novi, A., Vannelli, B., Thiele, C. J., Luzi, G., and Aiuti, F., Inflammatory cytokines and HIV-1-associated neurodegeneration: oncostatin-M produced by mononuclear cells from HIV-1-infected individuals induces apoptosis of primary neurons, J. Immunol., 162, 6268, 1999.
28. Elbim, C., Pillet, S., Prevost, M. H., Preira, A., Girard, P. M., Rogine, N., Matusani, H., Hakim, J., Israel, N., and Gougerot Pocidalo, M. A., Redox and activation status of monocytes from human immunodeficiency virus-infected patients: relationship with viral load, J. Virol., 73, 4561, 1999.
29. Wang, Y. and Watson, R. R., Is vitamin E supplementation a useful agent in AIDS therapy? Prog. Food Nutr. Sci., 17, 351, 1993.
30. de la Asuncion, J. G., del Olmo, M. L., Sastre, J., Millan, A., Pellin, A., Pallardo, F. V., and Vina, J., AZT treatment induces molecular and ultrastructural oxidative damage to muscle mitochondria. Prevention by antioxidant vitamins, J. Clin. Invest., 102, 4, 1998.
31. Cozzaglio, L., Doci, R., Colla, G., Zumino, F., Casciarri, G., and Genarri, L., A feasibility study of high-dose cisplatin and 5-fluorouracil with glutathione protection in the treatment of advanced colorectal cancer, Tumori, 76, 590, 1990.
32. Gandara, D. R., Perez, E. A., Weibe, V., and DeGregorio, M. W., Cisplatin chemoprotection and rescue: pharmacological modulation of toxicity, Semin. Oncol., 18, 49, 1991.
33. Ishikawa, M., Takayanagi, Y., and Sasaki, K. I., Enhancement of cisplatin toxicity by buthionine sulfoximine, a glutathion-depleting agent in mice, Res. Commun. Chem. Pathol. Pharmacol., 67, 131, 1990.
34. Levi, J., Jacobs, C., Kalman, S. B., Mctigue, M., and Weiner, M. W., Mechanism of cisplatinum nephrotoxicity: I. Effect of sulfhydryl groups in the rat kidneys, J. Pharmacol. Exp. Ther., 213, 545, 1980.
35. Zhang, J. and Lindup, E., Role of mitochondria in cisplatin-induced oxidative damage exhibited by rat renal cortical slices, Biochem. Pharmacol., 45, 2215, 1990.
36. Husain, K., Morris, C., Whithworth, C., Trammel, G. L., Rybak, L. P., and Somani, S. M., Protection by ebselen against cisplatin-induced nephrotoxicity: antioxidant system, Mol. Cell. Biochem., 178, 127, 1998.
37. Rybak, L. P., Husain, K., Whitworth, C., and Somani, S. M., Dose-dependent protection by lipoic acid against cisplatin-induced ototoxicity in rats: antioxidant defense system, Toxicol. Sci., 47, 195, 1999.
38. Gewirtz, D. A., A critical evaluation of the mechanism of action proposed for the antitumor effects of the anthracyclin antibiotics adriamycin and daunorubicin, Biochem. Pharmacol., 57, 727, 1999.
39. Bachur, N. R., Gordon, S. L., and Gee, M. V., Anthracyclin antibiotic augmentation of microsomal electron transport and free radical formation, Mol. Pharmacol., 13, 901, 1977.
40. Eliot, H., Gianni, L., and Myers, C., Oxidative destruction of DNA by the adriamycin-iron complex, Biochemistry, 23, 928, 1994.
41. Wexler, L. H., Andrich, M. P., Venzon, D., Berg, S. L., Weaver-McClure, L., Chen, C. C., Dilsizian, V., Avila, N., Jarosinski, P., Balis, F. M., Poplack, D. G., and Horowitz, M. E., Randomized trials of the cardioprotective agent ICR-187 in pediatric sarcoma patients treated with doxorubicin, J. Clin. Oncol., 14, 362, 1996.
42. Parizada, B., Werber, M. M., and Nimrod, A., Protective effects of human recombinant MnSOD in adjuvant arthritis and bleomycin-induced lung fibrosis, Free Radical Res. Commun., 15, 297, 1991.
43. Lopez-Larraza, D., De-Luca, J. C., and Bianchi, N. O., The kinetics of DNA damage by bleomycin in mammalian cells, Mutat. Res., 232, 57, 1990.
44. Nakamura, M., Lactoferrin-mediated formation of oxygen radicals by NADPH-cytochrome P-450 reductase system, J. Biochem. Tokyo, 107, 395, 1990.
45. Kilinc, C., Ozcan, O., Karaoz, E. Sunguroglu, K., Kutluay, T., and Karaca, L., Vitamin E reduces bleomycin-induced lung fibrosis in mice: biochemical and morphological studies, J. Basic Clin. Physiol. Pharmacol., 4, 249, 1993.
46. Nici, L., Santos-Moore, A., Kuhn, C., and Calabresi, P., Modulation of bleomycininduced pulmonary toxicity in the hamster by the antioxidant amifostine, Cancer, 83, 2008, 1998.
47. Sinha, B. K. and Mimnaugh, E. G., Free radicals and anticancer drug resistance: oxygen free radicals in the mechanisms of drug cytotoxicity and resistance by certain tumors (adriamycin and mitomycin C), Free Radical Biol. Med., 8, 567, 1990.
48. Millart, H., Kantelip, J. P., Platonoff, N., Descous, I., Trenque, T., Lamiable, D., and Choisy, H., Increased iron content in rat myocardium after 5-fluorouracil chronic administration, Anticancer Res., 13, 779, 1993.
49. Burkle, A., Chen, G., Kupper, J. H., Grube, K., and Zeller, W. J., Increased poly(ADPribosyl) ation in intact cells by cisplatin treatment, Carcinogenesis, 14, 559, 1993.
50. Thiemermann, C., Bowes, J., Myint, F. P., and Vane, J. R., Inhibition of the activity of poly(ADP-ribose) synthetase reduces ischemia-reperfusion injury in the heart and skeletal muscle, Proc. Natl. Acad. Sci. U.S.A., 94, 679, 1997.
51. Szabó, C., Zingarelli, B., O’Connor, M., and Salzman, A. L., DNA strand breakage, activation of poly(ADP-ribose) synthetase, and cellular energy depletion are involved in the cytotoxicity of macrophages and smooth muscle cells exposed to peroxynitrite, Proc. Natl. Acad. Sci. U.S.A., 93, 1753, 1996.
52. Szabó, C. and Dawson, V. L., Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion, Trends Pharmacol. Sci., 19, 287, 1998.
53. Zingarelli, B., Cuzzocrea, S., Zsengeller, Z., Salzman, A. L., and Szabó, C., Protection against myocardial ischemia and reperfusion injury by 3-aminobenzamide, an inhibitor of poly(ADP-ribose) synthetase, Cardiovasc. Res., 36, 205, 1997.
54. Althaus, E. M. and Richter, C., ADP-ribosylation of proteins. Enzymology and biological significance, Mol. Biol. Biochem. Biophys., 37, 1, 1987.
55. Bowman, K. J., White, A., Golding, B. T., Griffin, R. J., and Curtin, N. J., Potentiation of anti-cancer agent cytotoxicity by the potent poly(ADP-ribose)polymerase inhibitors NU1025 and NU1064, Br. J. Cancer, 78, 1269,1998.
56. Boike, G. M., Petru, E., Sevin, B. U. et al., Chemical enhancement of cisplatin cytotoxicity in a human ovarian and cervical cancer cell line, Gynecol. Oncol., 38, 315, 1990.
57. Chen, G. and Pan, Q. C., Potentiation of the antitumor activity of cisplatin in mice by 3-aminobenzamide, Cancer Chemother. Pharmacol., 22, 303, 1988.
58. Boorstein, R. J. and Pardee, A. B., Factors modifying 3-aminobenzamide cytotoxicity in normal and repair-deficient human fibroblast, J. Cell. Physiol., 120, 335, 1984.
59. Bernges, F. and Zeller, W. J., Combination effects of poly(ADP-ribose)polymerase inhibitors and DNA-damaging agents in ovarian tumor cell lines -with special reference to cisplatin, J. Cancer Res. Clin. Oncol., 122, 665, 1996.
60. Chen, G. and Zeller, W. J., Reversal of acquired cisplatin resistance by nicotinamide in vitro and in vivo, Cancer Chemother. Pharmacol., 33, 157, 1993.
61. Dantzer, S. V., Niedergang, C., Trucco, C., Flatter, E., de la Rubia, G., Oliver, F. J., Rolli, V., and Menissier-de Murcia, J., Role of poly(ADP-ribose)polymerase in base excision repair, Biochimie, 81, 69, 1991.
62. Wang, Z. and Wu, X., Nucleotide excision repair of DNA in cell-free extract of the yeast Saccaromyces cerevisiae, Proc. Natl. Acad. Sci. U.S.A., 90, 4907, 1993.
63. Henkels, K. M. and Turchi, J. J., Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines, Cancer Res., 59, 3077, 1999.
64. Zhan, Y., Van de Water, B., Wang, Y., and Stevens, J. L., The roles of caspase-3 and bcl-2 in chemically-induced apoptosis but necrosis of renal epithelial cells, Oncogene, 18, 6505, 1999.
65. Gong, J. G., Costanzo, A., Yang, H. Q., Melino, G., Kaelin, W. G., Jr., Levrero, M., and Wang, J. Y., The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage, Nature, 399, 806, 1999.
66. Basu, A. and Akkaraju, G. R., Regulation of caspase activation and cis-diamminedichloroplatinum(II)-induced cell death by protein kinase C, Biochemistry, 38, 4245, 1999.
67. Oliver, F. J., Menissier-de Murcia, J., and de Murcia, G., Poly(ADP-ribose) polymerase in the cellular response to DNA damage, apoptosis, and disease, Am. J. Hum. Genet., 64, 1282, 1999.
68. Casciola-Rosen, L., Nicholson, D. W., Chong, T., Rowan, K. R., Thornberry, N. A., Miller, D. K., and Rosen, A., Apopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic death, J. Exp. Med., 183, 1957, 1996.
69. Le Cam, F., Fack, F., Menissier-de Murcia, J., Cognet, J. A., Barbin, A., Sarantoglu, V., and Revet, B., Conformational analysis of a 139 base-pair DNA fragment containing a single-stranded break and its interaction with human poly(ADP-ribose) polymerase, J. Mol. Biol., 235, 1062, 1994.
70. Eliasson, M. J. L., Sampei, K., Mandir, A. S., Hurn, P. D., Traystman, R. J., Bao, J., Pieper, A., Wang, Z. Q., Dawson, T. M., Snyder, S. H., and Dawson, V. L., Poly(ADPribose) polymerase gene disruption renders mice resistant to celebral ischaemia, Nat. Med., 3, 1089, 1994.
71. Mizumoto, K., Glascott, P. A., Jr., and Farber, J. L., Roles of oxidative stress and poly(ADP-ribosyl)ation in the killing of cultured hepatocytes by methyl methanesulfonate, Biochem. Pharmacol., 46, 1811, 1993.
72. Said, S. I., Berisha, H. I., and Pakbaz, H., Excitotoxicity in the lung: N-Methyl-Dasparate-induced, nitric oxide-dependent, pulmonary edema is attenuated by vasoactive intestinal peptide and by inhibitors of poly(ADP-ribose) polymerase, Proc. Natl. Acad. Sci. U.S.A., 93, 4688, 1996.
73. Wang, Z. Q., Auer, B., Stingl, L., Berghammer, H., Haidacher, D., Schweiger, M., and Wagner, E. F., Mice lacking ADPRT and poly-ADP-ribosylation develop normally but are susceptible to skin disease, Genes Dev., 9, 509, 1995.
74. MacFarlane, P. W. and Lawrie, T. D. V., Comprehensive Electrocardiology, Pergamon Press, Oxford, 1989.
75. Sumegi, B., Melegh, B., Adamovich, K., and Trombitas, K., Cytochrome oxidase deficiency affecting the structure of the myofiber and the shape of cristal membrane, Clin. Chim. Acta, 192, 9, 1990.
76. Sumegi, B., Gilbert, H. F., and Srere, P. A., Interaction between citrate synthase and thiolase, J. Biol. Chem., 260, 188, 1985.
77. Abul-Ezz, S. R., Walker, P. D., and Shah, S. V., Role of glutathione in an animal model of myoglobinuric acute renal failure, Proc. Natl. Acad. Sci. U.S.A., 88, 9833, 1991.
78. Scudiero, D. A., Shoemaker, R. H., Paull, K. D., Monks, A., Tierney, S., Nofzinger, T. H., Currens, M. J., Seniff, D., and Boyd, M. R., Evaluation of a soluble tetrezolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines, Cancer Res., 48, 4827, 1988.